INDEX ANNOUNCEMENT

Aveo Group to be removed from the S&P/ASX 200 Index

SYDNEY, NOVEMBER 7, 2019: S&P Dow Jones Indices announced today that it will remove Aveo

Group (XASX: AOG) from the S&P/ASX 200, subject to final court approval of the scheme of arrangement whereby the company will be acquired by Brookfield Asset Management Inc.

S&P Dow Jones will remove Aveo Group from the S&P/ASX 200 effective at the open of trading on November 14, 2019. Aveo Group will be replaced by Avita Medical Ltd (XASX: AVH) in the S&P/ASX 200 effective at the open on November 14, 2019.

For more information about S&P Dow Jones Indices, please visit www.spdji.com.

ABOUT S&P DOW JONES INDICES

S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has become home to over 1,000,000 indices across the spectrum of asset classes that have helped define the way investors measure and trade the markets.

S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies and governments to make decisions with confidence. For more information, visit www.spdji.com.

FOR MORE INFORMATION:

S&P Dow Jones Indicesindex_services@spglobal.com

INDEX ANNOUNCEMENT

Attachments

  • Original document
  • Permalink

Disclaimer

Aveo Group Ltd. published this content on 07 November 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 November 2019 07:04:07 UTC